Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose The tertiary lymphoid structure (TLS) is an important source of tumor-infiltrating lymphocytes (TILs), which have a strong prognostic and predictive value in triple-negative breast cancer (TNBC). A previous study reported that the levels of CXCL13 mRNA expression were associated with TLSs, but measuring the gene expression is challenging in routine practice. Therefore, this study evaluated the MECA79-positive high endothelial venule (HEV) densities and their association with the histopathologically assessed TLSs in biopsy samples. In addition, the relationship of TLSs with the CXCL13 transcript levels and clinical outcomes were examined. Materials and Methods A total of 108 TNBC patients treated with neoadjuvant chemotherapy (NAC) were studied. The amounts of TILs and TLSs were measured histopathologically using hematoxylin and eosin–stained slides. The HEV densities and TIL subpopulations were measured by immunohistochemistry for MECA79, CD3, CD8, and CD20. CXCL13mRNA expression levels using a NanoString assay (NanoString Technologies). Results The mean number of HEVs in pre-NAC biopsies was 12 (range, 0 to 72). The amounts of TILs and TLSs, HEV density, and CXCL13 expression showed robust correlations with each other. A lower pre-NAC clinical T stage, higher TIL and TLS levels, a higher HEV density, CD20- positive cell density, and CXCL13 expression were significant predictors of a pathologic complete response (pCR). Higher CD8-positive cell density and levels of CXCL13 expression were significantly associated with a better disease-free survival rate. Conclusion MECA79-positive HEV density in pre-NAC biopsies is an objective and quantitative surrogate marker of TLS and might be a valuable tool for predicting pCR of TNBC in routine pathology practice.
Abstract
Purpose The tertiary lymphoid structure (TLS) is an important source of tumor-infiltrating lymphocytes (TILs), which have a strong prognostic and predictive value in triple-negative breast cancer (TNBC). A previous study reported that the levels of CXCL13 mRNA expression were associated with TLSs, but measuring the gene expression is challenging in routine practice. Therefore, this study evaluated the MECA79-positive high endothelial venule (HEV) densities and their association with the histopathologically assessed TLSs in biopsy samples. In addition, the relationship of TLSs with the CXCL13 transcript levels and clinical outcomes were examined. Materials and Methods A total of 108 TNBC patients treated with neoadjuvant chemotherapy (NAC) were studied. The amounts of TILs and TLSs were measured histopathologically using hematoxylin and eosin–stained slides. The HEV densities and TIL subpopulations were measured by immunohistochemistry for MECA79, CD3, CD8, and CD20. CXCL13mRNA expression levels using a NanoString assay (NanoString Technologies). Results The mean number of HEVs in pre-NAC biopsies was 12 (range, 0 to 72). The amounts of TILs and TLSs, HEV density, and CXCL13 expression showed robust correlations with each other. A lower pre-NAC clinical T stage, higher TIL and TLS levels, a higher HEV density, CD20- positive cell density, and CXCL13 expression were significant predictors of a pathologic complete response (pCR). Higher CD8-positive cell density and levels of CXCL13 expression were significantly associated with a better disease-free survival rate. Conclusion MECA79-positive HEV density in pre-NAC biopsies is an objective and quantitative surrogate marker of TLS and might be a valuable tool for predicting pCR of TNBC in routine pathology practice.
참고문헌 (28)
- Aaltomaa S, "Lymphocyte infiltrates as a prognostic variable in female breast cancer", Eur J Cancer, 28A, pp.859~864 (1992)
- Clemente CG, "Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma", Cancer, 77, pp.1303~1310 (1996)
- 이희진, "Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients", Journal of Breast Cancer, 16(1), pp.32~39 (2013), 한국유방암학회[DOI]
- 안성귀, "Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer", Journal of Pathology and Translational Medicine, 49(5), pp.355~363 (2015), 대한병리학회[DOI]
- West NR, "Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptornegative breast cancer", Breast Cancer Res, 13, pp.R126~ (2011)
- Stagg J, "Immunotherapeutic approaches in triplenegative breast cancer : latest research and clinical prospects", Ther Adv Med Oncol, 5, pp.169~181 (2013)
- Martinet L, "Human solid tumors contain high endothelial venules : association with T-and B-lymphocyte infiltration and favorable prognosis in breast cancer", Cancer Res, 71, pp.5678~5687 (2011)
- Lee HJ, "Prognostic significance of tumor-infiltrating lymphocytes and the tertiary lymphoid structures in HER2-positive breast cancer treated with adjuvant trastuzumab", Am J Clin Pathol, 144, pp.278~288 (2015)
- Martinet L, "High endothelial venules(HEVs)in human melanoma lesions : major gateways for tumor-infiltrating lymphocytes", Oncoimmunology, 1, pp.829~839 (2012)
- Girard JP, "HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes", Nat Rev Immunol, 12, pp.762~773 (2012)
- Ladanyi A, "Density of DC-LAMP(+)mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor", Cancer Immunol Immunother, 56, pp.1459~1469 (2007)
- Dieu-Nosjean MC, "Long-term survival for patients with nonsmall-cell lung cancer with intratumoral lymphoid structures", J Clin Oncol, 26, pp.4410~4417 (2008)
- Di Caro G, "Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in earlystage colorectal cancers", Clin Cancer Res, 20, pp.2147~2158 (2014)
- Gu-Trantien C, "CD4(+)follicular helper T cell infiltration predicts breast cancer survival", J Clin Invest, 123, pp.2873~2892 (2013)
- Lee HJ, "Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer : relationship to tumor-infiltrating lymphocytes", Breast Cancer Res Treat, 151, pp.619~627 (2015)
- Neyt K, "Tertiary lymphoid organs in infection and autoimmunity", Trends Immunol, 33, pp.297~305 (2012)
- Mahmoud SM, "Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer", J Clin Oncol, 29, pp.1949~1955 (2011)
- Liu S, "CD8+lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer", Breast Cancer Res, 14, pp.R48~ (2012)
- Schmidt M, "The humoral immune system has a key prognostic impact in node-negative breast cancer", Cancer Res, 68, pp.5405~5413 (2008)
- Brown JR, "Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer", Clin Cancer Res, 20, pp.5995~6005 (2014)
- Symmans WF, "Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy", J Clin Oncol, 25, pp.4414~4422 (2007)
- Salgado R, "The evaluation of tumor-infiltrating lymphocytes(TILs)in breast cancer : recommendations by an International TILs Working Group 2014", Ann Oncol, 26, pp.259~271 (2015)
- Geiss GK, "Direct multiplexed measurement of gene expression with color-coded probe pairs", Nat Biotechnol, 26, pp.317~325 (2008)
- Bellone M, "Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes", Front Oncol, 3, pp.231~ (2013)
- Mahmoud SM, "The prognostic significance of B lymphocytes in invasive carcinoma of the breast", Breast Cancer Res Treat, 132, pp.545~553 (2012)
- Seo AN, "Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer", Br J Cancer, 109, pp.2705~2713 (2013)
- 강한나, "삼중음성유방암에서 Foxp3 양성 조절 T세포와 종양 침윤 T림프구의 의의", Journal of Pathology and Translational Medicine, 45(1), pp.53~61 (2011), 대한병리학회
- Nelson BH, "CD20+ B cells : the other tumor-infiltrating lymphocytes", J Immunol, 185, pp.4977~4982 (2010)